Literature DB >> 9915824

Insulin promotes phosphorylation and activation of geranylgeranyltransferase II. Studies with geranylgeranylation of rab-3 and rab-4.

M L Goalstone1, J W Leitner, I Golovchenko, M R Stjernholm, M Cormont, Y Le Marchand-Brustel, B Draznin.   

Abstract

Rab proteins play a crucial role in the trafficking of intracellular vesicles. Rab proteins are GTPases that cycle between an inactive GDP-bound form and an active GTP-bound conformation. A prerequisite to Rab activation by GTP loading is its post-translational modification by the addition of geranylgeranyl moieties to highly conserved C-terminal cysteine residues. We examined the effect of insulin on the activity of geranylgeranyltransferase II (GGTase II) in 3T3-L1 fibroblasts and adipocytes. In fibroblasts, insulin increased the enzymatic activity of GGTase II 2.5-fold after 1 h of incubation, an effect that is blocked by perillyl alcohol, an inhibitor of prenyltransferases, but not by the geranylgeranyltransferase I inhibitor, GGTI-298, or the farnesyltransferase inhibitor, alpha-hydroxyfarnesylphosphonic acid. Concomitantly, insulin stimulated the phosphorylation of the GGTase II alpha-subunit without any effect on the GGTase II beta-subunit. At the same time, insulin also increased the amounts of geranylgeranylated Rab-3 in 3T3-L1 fibroblasts from 44 +/- 1.2% in control cells to 63 +/- 3.8 and 64 +/- 6.1% after 1 and 24 h of incubation, respectively. In adipocytes, insulin increased the amounts of geranylgeranylated Rab-4 from 38 +/- 0.6% in control cells to 56 +/- 1.7 and 60 +/- 2.6% after 1 and 24 h of incubation, respectively. In both fibroblasts and adipocytes, the presence of perillyl alcohol blocked the ability of insulin to increase geranylgeranylation of Rab-4, whereas GGTI-298 and alpha-hydroxyfarnesylphosphonic acid were without effect, indicating that insulin activates GGTase II. In summary, insulin promotes phosphorylation and activation of GGTase II in both 3T3 L1 fibroblasts and adipocytes and increases the amounts of geranylgeranylated Rab-3 and Rab-4 proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9915824     DOI: 10.1074/jbc.274.5.2880

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  GGPPS, a new EGR-1 target gene, reactivates ERK 1/2 signaling through increasing Ras prenylation.

Authors:  Ning Shen; Yue Shao; Shan-Shan Lai; Long Qiao; Run-Lin Yang; Bin Xue; Fei-Yan Pan; Hua-Qun Chen; Chao-Jun Li
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

2.  The branch point enzyme of the mevalonate pathway for protein prenylation is overexpressed in the ob/ob mouse and induced by adipogenesis.

Authors:  D Vicent; E Maratos-Flier; C R Kahn
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

3.  The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production.

Authors:  Karine Croizet-Berger; Chantal Daumerie; Marianne Couvreur; Pierre J Courtoy; Marie-France van den Hove
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Prenylation differentially inhibits insulin-dependent immediate early gene mRNA expression.

Authors:  J Lee Franklin; Maggie O Amsler; Joseph L Messina
Journal:  Biochem Biophys Res Commun       Date:  2016-04-14       Impact factor: 3.575

5.  Evidence of Rab3A expression, regulation of vesicle trafficking, and cellular secretion in response to heregulin in mammary epithelial cells.

Authors:  R K Vadlamudi; R A Wang; A H Talukder; L Adam; R Johnson; R Kumar
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

6.  An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism.

Authors:  Ning Shen; Xiao Yu; Fei-Yan Pan; Xiang Gao; Bin Xue; Chao-Jun Li
Journal:  J Biol Chem       Date:  2011-02-14       Impact factor: 5.157

7.  Trans, trans-farnesol as a mevalonate-derived inducer of murine 3T3-F442A pre-adipocyte differentiation.

Authors:  Sheida Torabi; Huanbiao Mo
Journal:  Exp Biol Med (Maywood)       Date:  2015-12-08

Review 8.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Statins in the treatment of polycystic ovary syndrome.

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Semin Reprod Med       Date:  2008-01       Impact factor: 1.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.